Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. All News
    SAN   FR0000120578

SANOFI

(SAN)
  Report
Real-time Euronext Paris  -  07:12 2022-12-05 am EST
85.40 EUR   -0.43%
12/03J&J unit says does not intend to bid for Horizon Therapeutics
RE
12/03J&J unit says does not intend to bid for Horizon Therapeutics
RE
12/02Weekly market update : One step forward, one step back
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about SANOFI
12/03J&J unit says does not intend to bid for Horizon Therapeutics
RE
12/03J&J unit says does not intend to bid for Horizon Therapeutics
RE
12/02Weekly market update : One step forward, one step back
MS
12/02European Equities Move Lower to End Strong Month, Week Lower
MT
12/02Is the job report good or bad news?
MS
12/02Sanofi Says Any Potential Offer for Horizon Therapeutics Will Be Made in Cash
MT
12/02French Drugmaker Sanofi to Only Consider Cash Offer for Ireland's Horizon Therapeutics
MT
12/02French company Sanofi: any offer for Horizon Therapeutics, if made..
RE
12/02Press Release : Statement from Sanofi regarding: rule 2.12 of the takeover rules
GL
12/02Press Release : Statement from Sanofi regarding: rule 2.12 of the takeover rules
AQ
12/02Sanofi Confirms That Any Offer for Horizon, If Made by Sanofi, Will Be Solely in Cash
CI
12/01SANOFI : UBS remains Neutral
MD
12/01SANOFI : Deutsche Bank sticks Neutral
MD
11/30Health Care Up as Biogen, Horizon Surge -- Health Care Roundup
DJ
11/30Sector Update: Health Care Carried Higher by Surging Biotechs
MT
11/30Sector Update: Health Care Stocks Still Struggling for Direction Wednesday..
MT
11/30Top Midday Gainers
MT
11/30Sector Update: Health Care
MT
11/30Global markets live: Apple, Tesla, Boeing, HP, Intuit...
MS
11/30European Equities Nudge Higher on Slightly Lower Euro Area Inflation
MT
11/30All eyes on Powell
MS
11/30Upwardly Revised Q3 GDP Ahead of Powell's Speech Lifts US Equities Higher Premarket
MT
11/30SANOFI : Credit Suisse remains its Buy rating
MD
11/30MarketScreener's World Press Review : November 30, 2..
MS
11/30North American Morning Briefing: Powell in Focus as Chin..
DJ
11/30Sanofi's Single-dose Pill Set To Become First Treatment For Deadly Sleeping Sickness Af..
MT
11/30Press Release : Acoziborole: Investigational single-dose oral treatment raises hope for el..
GL
11/30Press Release : Acoziborole: Investigational single-dose oral treatment raises hope for el..
GL
11/30SANOFI : Barclays reiterates its Neutral rating
MD
11/30Sanofi Medication Found 95% Effective at Curing Sleeping Sickness
MT
11/29British Health Regulator Flags Risk Of Serious Eye Reactions To Sanofi-Regeneron's Asth..
MT
11/29Sanofi in Early Deal Talks with Horizon Therapeutics
MT
11/29Stocks to Watch: Horizon Therapeutics, Workday, NetApp, Crowdstrike, Wayfair
DJ
11/29Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi
RE
11/29Horizon Therapeutics Confirms 'Highly Preliminary Discussions' With Three Suitors -- Sh..
MT
11/29Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi
RE
11/29UK regulator calls for review of reactions in eyes to Sanofi asthma drug
RE
11/29UK regulator says reactions in eye from Sanofi drug must be quickly reviewed
RE
11/29Horizon Therapeutics Confirms Preliminary Discussions Regarding Potential Offer
CI
11/28DRI Healthcare Trust Acquires Royalty Interest in Global Sales of Xenpozyme for Treatme..
MT
11/28Drugmaker Sanofi Relocates to New Paris Headquarters
MT
11/24U.S. Supreme Court To Decide On Enablement Standard For Biotech Antibody Patents In Amg..
AQ
11/21Sanofi Receives Marketing Authorization for Enjaymo from the European Commission
CI
11/21SANOFI : UBS remains Neutral
MD
11/18Vaccines and drugs in the pipeline for RSV
RE
11/18Provention Bio, Inc. - TZIELD approved by FDA as the first and only treatment indicated..
AQ
11/18Provention Bio diabetes drug to cost $13,850/vial
RE
11/17Sanofi Secures First-in-Class EU Nod for Rare Blood Disorder Drug Enjaymo
MT
11/17U.S. FDA greenlights Provention Bio's diabetes drug
RE
11/17U.S. FDA greenlights Provention Bio's diabetes drug
RE
11/17Sanofi Gets EU Marketing Authorization for Enjaymo to Treat Hemolytic Anemia
MT
11/17Sanofi Gets EU Nod on Hemolytic Anemia Drug
DJ
11/17Press Release : European Commission approves Enjaymo« (sutimlimab) for treatment of hemoly..
GL
11/17Press Release : European Commission approves Enjaymo« (sutimlimab) for treatment of hemoly..
AQ
11/17European Commission Approves Enjaymov for Treatment of Hemolytic Anemia in Adult Patien..
CI
11/17USSC Agrees To Reconsider Amgen Inc. V Sanofi On Enablement Of Antibody Genus Claims
AQ
11/17Cisen Pharmaceutical Gets Regulatory Approval for Registration of Two Drugs
MT
11/15Sanofi and GSK’s Next-Generation COVID-19 Booster Vaccine VidPrevtyn« Beta Approve..
CI
11/14Regeneron Pharmaceuticals Inc. - Dupixent Recommended for EU Approval by the CHMP for t..
AQ
11/14Sobi to present new data at the ASH 2022 Annual Meeting
AQ
11/14Supreme Court To Consider Enablement Requirement
AQ
11/11European ADRs Move Slightly Lower in Friday Trading
MT
11/11Sanofi and GSK's next-generation COVID-19 booster vaccine VidPrevtyn Beta approved by t..
AQ
11/11Regeneron, Sanofi Say European Medicines Agency Committee Recommends Approval of Dupixe..
MT
11/11Regeneron, Sanofi Get CHMP Backing for Dupixent in Prurigo Nodularis
DJ
11/11Press Release : Dupixent« (dupilumab) recommended for EU approval by the CHMP for the trea..
GL
11/11Press Release : Dupixent« (dupilumab) recommended for EU approval by the CHMP for the trea..
AQ
11/11Dupixent« (dupilumab) Recommended for EU Approval by the CHMP for the Treatment of Prur..
PR
11/11European Medicines Agency Backs Sanofi's COVID-19 Booster, Three Other Drugs for Novemb..
MT
11/11Amgen v. Sanofi Case On Enablement Of Antibody Genus Claims Will Be Heard At The Suprem..
AQ
11/10European Commission Approves Sanofi and GSK's Next-Generation Covid-19 Booster Vaccine ..
CI
11/10GSK Says Sanofi-GSK COVID Booster Vaccine Approved By EU
RE
11/10Sanofi, GSK's COVID-19 Booster Shot Gets Regulatory Nod in Europe
MT
11/10Sanofi-GSK COVID-19 Jab Gets EU Commission Approval as Booster
MT
11/10Press Release : Sanofi and GSK's next-generation COVID-19 booster vaccine VidPrevtyn« Beta..
GL
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on SANOFI